Clinical Trial Update: A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia

View source ↗

Summary

A randomized, open-label trial comparing voriconazole with liposomal amphotericin B (AmBisome) for empirical antifungal therapy in immunocompromised patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Neutropenia | Status: COMPLETED